Potential Association Between Magnesium Depletion Score and Hyperuricemia in American Adults, a Cross-sectional Study Based on NHANES 2003-2018

Overview

Journal Prev Med Rep

Date 2025 Mar 4

PMID 40034986

Authors

Zeyan Li

Maoyan Wu

Simin Kong

Bin Xiao

Affiliations

Soon will be listed here.

Abstract

Objective: The pathophysiological mechanisms underlying hyperuricemia necessitate the identification of contributing factors to better understand disease progression and develop effective therapies. This study aimed to investigate the association between Magnesium Depletion Score (MDS) and hyperuricemia.

Methods: A cross-sectional study was sourced from the National Health and Nutrition Examination Survey 2003-2018. Hyperuricemia was defined by serum uric acid levels. MDS was calculated by incorporating factors affecting renal magnesium reabsorption.Weighted multivariable logistic regression was employed to assess the association between MDS and hyperuricemia, with sensitivity analyses to confirm robustness. Additionally, Restricted Cubic Spline (RCS) and Receiver Operating Characteristic (ROC) curve analyses were used to further elucidate the relationship.

Results: Compared to the low MDS group (0-1), the odds ratios (OR) and 95 % confidence intervals (CI) for the middle MDS group (2) and high MDS group (3-5) were 1.76 (1.52-2.04), and 3.14(2.54-3.88), respectively. The RCS analysis illustrated a linear dose-response relationship between MDS and hyperuricemia. The ROC analysis demonstrated that MDS had an area under the curve of 0.720 (95 % CI, 0.717-0.721).

Conclusions: This study highlights a strong association between MDS and hyperuricemia risk, emphasizing the importance of addressing magnesium deficiency in hyperuricemic patients.

References

Choi Y, Yoon Y, Lee K, Hien T, Kang K, Kim K . Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J. 2014; 28(7):3197-204. DOI: 10.1096/fj.13-247148. View

Ciarambino T, Crispino P, Giordano M . Hyperuricemia and Endothelial Function: Is It a Simple Association or Do Gender Differences Play a Role in This Binomial?. Biomedicines. 2022; 10(12). PMC: 9775568. DOI: 10.3390/biomedicines10123067. View

Xu Y, Qin Y, Lu H, Liu L, Huang W, Huang A . The magnesium depletion score is associated with increased likelihood of kidney stone disease among female adults. J Trace Elem Med Biol. 2024; 84:127432. DOI: 10.1016/j.jtemb.2024.127432. View

Feig D, Kang D, Johnson R . Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17):1811-21. PMC: 2684330. DOI: 10.1056/NEJMra0800885. View

Ando R, Nagaya T, Suzuki S, Takahashi H, Kawai M, Taguchi K . Independent and interactive effects of kidney stone formation and conventional risk factors for chronic kidney disease: a follow-up study of Japanese men. Int Urol Nephrol. 2021; 53(6):1081-1087. DOI: 10.1007/s11255-021-02803-z. View

Wang K, Chen H, Wang J, Wang Y . Association between magnesium depletion score and chronic obstructive pulmonary disease risk: a secondary data analysis from NHANES. BMJ Open. 2024; 14(6):e083275. PMC: 11163619. DOI: 10.1136/bmjopen-2023-083275. View

Du L, Zong Y, Li H, Wang Q, Xie L, Yang B . Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024; 9(1):212. PMC: 11350024. DOI: 10.1038/s41392-024-01916-y. View

Horvathova V, Bohata J, Pavlikova M, Pavelcova K, Pavelka K, Senolt L . Interaction of the p.Q141K Variant of the Gene with Clinical Data and Cytokine Levels in Primary Hyperuricemia and Gout. J Clin Med. 2019; 8(11). PMC: 6912417. DOI: 10.3390/jcm8111965. View

Maloberti A, Bombelli M, Facchetti R, Barbagallo C, Bernardino B, Agabiti Rosei E . Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study. J Hypertens. 2020; 39(2):333-340. DOI: 10.1097/HJH.0000000000002600. View

10.

Manganaro M . [Hyperuricemia in Chronic Kidney Disease: To Treat or Not to Treat?]. G Ital Nefrol. 2024; 41(Suppl 83). View

11.

Sakaguchi Y . The emerging role of magnesium in CKD. Clin Exp Nephrol. 2022; 26(5):379-384. PMC: 9012765. DOI: 10.1007/s10157-022-02182-4. View

12.

Song J, Zhang Y, Lin Z, Tang J, Yang X, Liu F . Higher Magnesium Depletion Score Increases the Risk of All-cause and Cardiovascular Mortality in Hypertension Participants. Biol Trace Elem Res. 2024; 203(3):1287-1296. DOI: 10.1007/s12011-024-04254-w. View

13.

Yanagawa T, Koyano K, Azuma K . Retrospective study of factors associated with progression and remission/regression of diabetic kidney disease-hypomagnesemia was associated with progression and elevated serum alanine aminotransferase levels were associated with remission or.... Diabetol Int. 2021; 12(3):268-276. PMC: 8172700. DOI: 10.1007/s13340-020-00483-1. View

14.

Melena I, Piani F, Tommerdahl K, Severn C, Chung L, MacDonald A . Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study. J Diabetes Complications. 2022; 36(6):108203. PMC: 9119939. DOI: 10.1016/j.jdiacomp.2022.108203. View

15.

Cheng G, Wang R, Zhang B, Deng X . The protective effect of uric acid in reducing TLR4/NF-κB activation through the inhibition of HMGB1 acetylation in a model of ischemia-reperfusion injury in vitro. Mol Biol Rep. 2020; 47(4):3233-3240. DOI: 10.1007/s11033-020-05324-7. View

16.

Fan L, Zhu X, Rosanoff A, Costello R, Yu C, Ness R . Magnesium Depletion Score (MDS) Predicts Risk of Systemic Inflammation and Cardiovascular Mortality among US Adults. J Nutr. 2021; 151(8):2226-2235. PMC: 8349125. DOI: 10.1093/jn/nxab138. View

17.

Jahnen-Dechent W, Ketteler M . Magnesium basics. Clin Kidney J. 2015; 5(Suppl 1):i3-i14. PMC: 4455825. DOI: 10.1093/ndtplus/sfr163. View

18.

Rabbani E, Golgiri F, Janani L, Moradi N, Fallah S, Abiri B . Randomized Study of the Effects of Zinc, Vitamin A, and Magnesium Co-supplementation on Thyroid Function, Oxidative Stress, and hs-CRP in Patients with Hypothyroidism. Biol Trace Elem Res. 2021; 199(11):4074-4083. DOI: 10.1007/s12011-020-02548-3. View

19.

Chen Y, Liu Q, Meng X, Zhao L, Zheng X, Feng W . Catalpol ameliorates fructose-induced renal inflammation by inhibiting TLR4/MyD88 signaling and uric acid reabsorption. Eur J Pharmacol. 2024; 967:176356. DOI: 10.1016/j.ejphar.2024.176356. View

20.

Yang K, Dong G, Tian Y, Li J . Effects of compound Danshen injection combined with magnesium sulfate on serum MPO and hs-CRP in patients with severe preeclampsia. Exp Ther Med. 2018; 16(1):167-170. PMC: 5995028. DOI: 10.3892/etm.2018.6173. View